A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Carmat requires €3.5m “urgently” and around €35m over the next 12 months to continue operations. Image credit: ArtemisDiana via Shutterstock. France-based Carmat has filed for insolvency and requested ...

In the trial, patients experienced a 24-point improvement in their Kansas City Cardiomyopathy Questionnaire score. Credit: Jo Panuwat D / Shutterstock. Foldax has revealed one-year outcomes from the ...

2 million individuals in the US live with type 1 diabetes and a rising number of type 2 patients require basal-bolus insulin therapy. Credit: Halfpoint via Shutterstock. The integration of Abbott’s ...

Medtronic Diabetes has entered a partnership with professional tennis player Alexander Zverev to launch “Life Without Limits” – a global awareness campaign aimed at highlighting how diabetes ...

The platform aims to minimise the requirement of several clinicians during procedures, which is especially beneficial amidst nurse shortages. Credit: Robert Kneschke / Shutterstock. NanoVibronix has ...

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...